Despite the inclusion of new medications for the treatment of obesity and diabetes in the Cuadro Básico de Medicamentos, access remains limited for patients. Endocrinology expert, Dolores Mejía, emphasizes that the approval for coverage by the Administradoras de Riesgos de Salud is still pending. She insists on the need to make these treatments accessible in order to improve the health of Dominicans in the face of the obesity and diabetes epidemic.